Earnings Feed
Start Free
Home/Filings/4/0000899243-20-033468
4//SEC Filing

Hofmeister Robert 4

Accession 0000899243-20-033468

CIK 0001750019other
View on SEC.govCompany Profile

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 6:11 AM ET

Size

6.0 KB

Accession

0000899243-20-033468

Insider Transaction Report

Form 4
Period: 2020-12-10
TCR2 THERAPEUTICS INC.TCRR
Hofmeister Robert
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-12-10+76,000→ 76,000 total
    Exercise: $31.83Exp: 2030-12-09→ Common Stock (76,000 underlying)
Holdings

  • Common Stock

    38,850
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.

Documents

1 file

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

→
Entity typeother

Related Parties

1
  • filerCIK 0001760102

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 6:11 AM ET
Size
6.0 KB
View on SEC.gov